Thương Trần

Dr. Thương Trần


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2025 in Diagnostics
Verified
Journal Article
Open access
TTThương Trần
Thương Trần
DTDien Minh Tran
Dien Minh Tran
NNNgoc Lan Nguyen
Ngoc Lan Nguyen
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Background: Vitamin D-dependent rickets type 1A (VDDR1A) is a rare autosomal recessive disorder caused by mutations in the CYP27B1 gene, leading to a deficiency in active vitamin D (1,25-dihydroxyvitamin D). This study examines the genotypic and phenotypic characteristics of VDDR1A in Vietnamese children. Patients and Methods: A retrospective analysis was conducted on 19 Vietnamese children diagnosed with VDDR1A. Clinical, radiological, biochemical, and molecular data were collected. Rickets Severity Scores (RSSs), biochemical parameters, and height standard deviation scores (HtSDSs) were used to assess the severity of the condition. Results: The study included 19 children from 17 families (ten males and nine females). The median age of rickets diagnosis was 19.2 months, while with VDDR1A, the median time of diagnosis was 7.5 months. Common symptoms among the children included thickened wrists and ankles (19/19), genu varum or genu valgum (18/19), failure to thrive (18/19), rachitic rosary (12/19), and delayed walking (11/19). The radiographic features showed that all children had cupping, splaying, and fraying, twelve children had rachitic rosary, and six exhibited pseudofractures. The biochemical findings showed severe hypocalcemia, normal or mildly low serum phosphate, elevated alkaline phosphatase and parathyroid hormone levels, and normal serum 25-hydroxyvitamin D levels. Genetic analysis identified biallelic CYP27B1 variants, including one known pathogenic frameshift mutation, c.1319_1325dup p.(Phe443Profs*24), one novel likely pathogenic missense variant, c.616C>T p.(Arg206Cys), and one novel pathogenic frameshift mutation, c.96_97del p.(Ala33Thrfs*299). The c.1319_1325dup p.(Phe443Profs*24) variant was the most common, present in 18 out of 19 children. Conclusions: The children with VDDR1A in this study presented with growth failure and skeletal deformities. Key findings included severe hypocalcemia, elevated alkaline phosphatase and parathyroid hormone levels, normal or elevated 25(OH)D, and high RSSs. Predominant frameshift mutations in CYP27B1, especially c.1319_1325dup, highlighted the importance of early genetic diagnosis for optimal management. Additionally, two novel CYP27B1 variants were identified, expanding the known mutation spectrum of VDDR1A.

28 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
TTThương Trần
Thương Trần
DTDien Minh Tran
Dien Minh Tran
NNNgoc Lan Nguyen
Ngoc Lan Nguyen
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Vitamin D-dependent rickets type 1A (VDDR1A) is a rare autosomal recessive disorder caused by mutations in the CYP27B1 gene, leading to a deficiency in active vitamin D (1,25-dihydroxyvitamin D). This study examines the genotypic and phenotypic characteristics of VDDR1A in Vietnamese children. A retrospective analysis was conducted on 19 Vietnamese children diagnosed with VDDR1A. Clinical, radiological, biochemical, and molecular data were collected. Rickets severity score (RSS), biochemical parameters, and height standard deviation score (HtSDS) were used to assess the severity of the condition. The study included 19 children from 17 families (10 males and nine females). The median age of rickets diagnosis was 19.2 months and with VDDR1A, while the median age of VDDR1A diagnosis was 7.5 months. Common symptoms among the children included thickened wrists and ankles (19/19), genu varum or genu valgum (18/19), failure to thrive (18/19), rachitic rosary (12/19), and delayed walking (11/19). Radiographic features showed that all children had cupping, splaying, and fraying, 12 children had rachitic rosary, and six exhibited pseudofracture. Biochemical findings showed severe hypocalcemia, normal or mildly low serum phosphate, elevated alkaline phosphatase and parathyroid hormone levels, and normal serum 25-hydroxyvitamin D level. Genetic analysis identified biallelic CYP27B1 variants, including one known pathogenic frameshift mutation c.1319_1325dup p.(Phe443Profs*24), one novel likely pathogenic missense variant c.616C>T p.(Arg206Cys), and one novel pathogenic frameshift mutation c.96_97del p.(Ala33Thrfs*299). The c.1319_1325dup p.(Phe443Profs*24) variant was the most common, present in 18 out of 19 children. Children with VDDR1A in this study presented with growth failure and skeletal deformities. Key findings included severe hypocalcemia, elevated alkaline phosphatase and parathyroid hormone levels, normal or elevated 25(OH)D, and high RSS. Predominant frameshift mutations in CYP27B1, especially c.1319_1325dup, highlight the importance of early genetic diagnosis for optimal management. Additionally, two novel CYP27B1 variants were identified, expanding the known mutation spectrum of VDDR1A.

16 June 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HNHong Thi Thuy Nguyen
Hong Thi Thuy Nguyen
MLMinh Khanh Le
Minh Khanh Le
TTThương Trần
Thương Trần
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Background/Objectives: Children with congenital adrenal hyperplasia (CAH) face significant risks of impaired growth and metabolic disturbances despite standard glucocorticoid therapy. This cross-sectional study aimed to evaluate growth outcomes, nutritional status, and associated factors among children with CAH treated in a Vietnamese tertiary pediatric center. Methods: We assessed 201 children aged 1.1–16.5 years in a tertiary pediatric center in Vietnam for anthropometric parameters, biochemical markers (calcium, phosphate, 25-hydroxyvitamin D), and clinical features. Growth status was evaluated using WHO standards, and bone age was assessed radiographically. Statistical analyses explored associations between growth outcomes and clinical, biochemical, and treatment-related factors. Results: Stunting was present in 16.4% of children, while 53.3% were overweight or obese. Bone age advancement occurred in 51.7% of cases. Vitamin D insufficiency or deficiency was detected in 85.6% of patients, and hypocalcemia was present in 85.1%. Overweight/obesity, vitamin D deficiency, and bone age advancement were associated with older age, prolonged corticosteroid therapy, higher androgen levels, and clinical features of treatment imbalance (e.g., Cushingoid appearance, hyperpigmentation). Female sex was significantly associated with higher rates of stunting. Conclusions: Growth impairment, nutritional deficiencies, and skeletal maturation disturbances are prevalent among children with CAH in Vietnam. Early identification of risk factors and the implementation of tailored management strategies that address both endocrine and nutritional health are crucial for optimizing long-term outcomes.

12 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HNHong Thi Thuy Nguyen
Hong Thi Thuy Nguyen
MLMinh Khanh Le
Minh Khanh Le
TTThương Trần
Thương Trần
KNKhanh Ngoc Nguyen
Khanh Ngoc Nguyen
NCNgoc Thi Bich Can
Ngoc Thi Bich Can
CVChi Dung Vu
Chi Dung Vu
Background/Objectives: Children with congenital adrenal hyperplasia (CAH) face significant risks of impaired growth and metabolic disturbances despite standard glucocorticoid therapy. This cross-sectional study aimed to evaluate growth outcomes, nutritional status, and associated factors among children with CAH treated in a Viet-namese tertiary pediatric center. Methods: We assessed 201 children aged 1.1–16.5 years in a tertiary pediatric center in Vietnam for anthropometric parameters, biochemical markers (calcium, phosphate, 25-hydroxyvitamin D), and clinical features. Growth status was evaluated using WHO standards, and bone age was assessed radiographically. Statistical analyses explored associations between growth outcomes and clinical, bio-chemical, and treatment-related factors. Results: Stunting was present in 16.4% of chil-dren, while 53.3% were overweight or obese. Bone age advancement occurred in 51.7% of cases. Vitamin D insufficiency or deficiency was detected in 85.6%, and hypocalcemia in 95% of patients. Overweight/obesity, vitamin D deficiency, and bone age advancement were associated with older age, prolonged corticosteroid therapy, higher androgen levels, and clinical features of treatment imbalance (e.g., Cushingoid appearance, hyperpig-mentation). Female sex was significantly associated with higher rates of stunting. Con-clusions: Growth impairment, nutritional deficiencies, and skeletal maturation dis-turbances are prevalent among children with CAH in Vietnam. Early identification of risk factors and tailored management strategies addressing both endocrine and nutritional health are crucial for optimizing long-term outcomes.

27 February 2025 in Tạp chí Nghiên cứu Y học
Verified
Journal Article
Open access
PDF file
TTThương Trần
Thương Trần
NKNguyễn Ngọc Khánh
Nguyễn Ngọc Khánh
BTBùi Phương Thảo
Bùi Phương Thảo
CNCấn Thị Bích Ngọc
Cấn Thị Bích Ngọc
NHNguyễn Thị Thuý Hồng
Nguyễn Thị Thuý Hồng
VDVũ Chí Dũng
Vũ Chí Dũng
Còi xương phụ thuộc Vitamin D loại 1A (VDDR1A) là bệnh hiếm gặp, di truyền gen lặn trên nhiễm sắc thể thường. Biến thể gây bệnh trên gen CYP27B1 gây thiếu hụt enzyme 1α-hydroxylase chuyển 25(OH)D thành 1,25(OH)2D. Hậu quả gây biến dạng xương dài, chậm tăng trưởng thể chất, chậm biết đi thậm chí co giật do hạ calci. Cận lâm sàng giảm nặng calci máu, tăng cao hoạt độ phosphatase kiềm và PTH, 25(OH)D bình thường hoặc tăng. Điều trị với calcitriol đem lại hiệu quả cải thiện cả lâm sàng và xét nghiệm. Nghiên cứu loạt ca bệnh, đối chứng trước và sau điều trị ở 19 trẻ được chẩn đoán còi xương phụ thuộc Vitamin D loại 1A, tại Trung tâm Nội tiết-Chuyển hoá-Di truyền và Liệu pháp Phân tử, Bệnh viện Nhi Trung ương đến 10/2024.Trong nghiên cứu có 10 trẻ nam (52,6%) và 9 trẻ nữ (47,4%). Tuổi chẩn đoán trung vị là 19,2 tháng. Tại thời điểm chẩn đoán các trẻ đều thấp lùn rõ với trung vị độ lệch chuẩn về chiều cao là -3SD (WHO), các triệu chứng lâm sàng điển hình là chân vòng kiềng hoặc chân chữ X, vòng cổ tay cổ chân gặp ở hầu hết trẻ. Biến đổi hoá sinh đều có hạ nặng calci, phopshat máu bình thường hoặc giảm, ALP và PTH tăng rõ, 25(OH)D bình thường, X-quang đầu xương dài có tình trạng nham nhở, bè rộng các đầu xương.Tình trạng biến dạng xương, nồng độ calci máu, ALP, PTH được cải thiện rõ rệt sau 12 đến 18 tháng điều trị. Điều trị VDDR1A bằng calcitriol và calci nguyên tố đem lại hiệu quả tốt về cải thiện nồng độ calci máu cũng như biến dạng về xương.